Top

Published in:

04-04-2023 | Breast Cancer

The Benefits of Screening Mammography

Authors: Charles De Jesus, Tanya W. Moseley, Valentina Diaz, Varnita Vishwanath, Shanen Jean, Ahmed Elhatw, Hanna R. Ferreira Dalla Pria, Hannah L. Chung, Mary S. Guirguis, Miral M. Patel

Published in: Current Breast Cancer Reports | Issue 2/2023

Abstract

Purpose of Review

Breast cancer is the most commonly diagnosed cancer worldwide. Early detection through screening mammography has been proven to reduce mortality, morbidity, and years of life lost. The purpose of this review is to discuss the benefits of screening mammography and the latest recommendations from the American College of Radiology (ACR).

Recent Findings

Approximately 300,000 new cases of breast cancer are diagnosed in the USA yearly. Screening mammography has allowed for early cancer detection with increasing efficacy leading to 500 prevented deaths for every 100,000 women screened and a 5-year survival rate of 91%.

Summary

Mammography screening promotes the earlier detection of breast cancer, hence minimizing mortality, years of life lost, and treatment morbidity associated with advanced breast cancer at the time of diagnosis.

Breastcancer.org. Breast cancer facts and statistics. Updated November 21, 2022. Accessed January 11, 2023. https://www.breastcancer.org/facts-statistics.

American College of Radiology. ACR practice parameter for the performance of screening and diagnostic mammography. Revised 2018. Accessed January 11, 2023. https://www.acr.org/-/media/ACR/Files/Practice-Parameters/screen-diag-mammo.pdf.

• American Cancer Society. Key statistics for breast cancer in men. Updated January 12, 2022. Accessed January 11, 2023. https://www.cancer.org/cancer/breast-cancer-in-men/about/key-statistics.html. Findings from this article remind readers that although uncommon, breast cancer can occur in men.

Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, Chiu SY, Chen SL, Fann JC, Rosell J, Fohlin H, Smith RA, Duffy SW. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260(3):658–63. https://doi.org/10.1148/radiol.11110469.CrossRefPubMed

Coldman A, Phillips N, Wilson C, Decker K, Chiarelli AM, Brisson J, Zhang B, Payne J, Doyle G, Ahmad R. Pan-Canadian study of mammography screening and mortality from breast cancer. J Natl Cancer Inst. 2014; 106(11):dju261. https://doi.org/10.1093/jnci/dju261. Erratum in: J Natl Cancer Inst. 2015;107(1):dju404. https://doi.org/10.1093/jnci/dju404.

National Cancer Institute Dictionaries. Mortality. Accessed January 11, 2023. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/mortality.

Lauby-Secretan B, Scoccianti C, Loomis D, Benbrahim-Tallaa L, Bouvard V, Bianchini F, Straif K, International Agency for Research on Cancer Handbook Working Group. Breast-cancer screening--viewpoint of the IARC Working Group. N Engl J Med. 2015;372(24):2353–8. https://doi.org/10.1056/NEJMsr1504363.CrossRefPubMed

Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (Eds.) SEER Cancer Statistics Review, 1975–2010, National Cancer Institute, Bethesda, MD (2012) SEER data submission, posted to the SEER web site based on November April 2013. [Cited 2020 Apr 21] Available from: https://seer.cancer.gov/archive/csr/1975_2010/

• Hooshmand S, Reed WM, Suleiman ME, Brennan PC. A review of screening mammography: the benefits and radiation risks put into perspective. J Med Imaging Radiat Sci. 2022;53(1):147–58. https://doi.org/10.1016/j.jmir.2021.12.002. (Findings from this study demonstrate the benefits of breast cancer screening mammography and discuss the associated risk of ionizing radiation.)CrossRefPubMed

10.

Myers ER, Moorman P, Gierisch JM, Havrilesky LJ, Grimm LJ, Ghate S, Davidson B, Mongtomery RC, Crowley MJ, McCrory DC, Kendrick A, Sanders GD. Benefits and harms of breast cancer screening. JAMA. 2015;314(15):1615. https://doi.org/10.1001/jama.2015.13183.CrossRefPubMed

11.

Health Knowledge. Years of life lost. Revised 2018. Accessed January 11, 2023. https://www.healthknowledge.org.uk/public-health-textbook/research-methods/1a-epidemiology/years-lost-life.

12.

Oeffinger KC, Fontham ETH, Etzioni R, Herzig A, Michaelson JS, Shih YCT, Walter LC, Church TR, Flowers CR, LaMonte SJ, Wolf AMD, DeSantis C, Lortet-Tieulent J, Andrews K, Manassaram-Baptiste D, Saslow D, Smith RA, Brawley OW, and Wender R. Breast cancer screening for women at average risk: 2015 Guideline update from the American cancer society. In JAMA – J Am Med Assoc. 2015; 314(15). https://doi.org/10.1001/jama.2015.12783

13.

Hendrick, R. E., & Helvie, M. A. (2012). Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death. Am J Roentgenol. 2012; 198(3). https://doi.org/10.2214/AJR.11.7146

14.

Hendrick RE, Helvie MA, and Hardesty LA. Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40–49 years old. Am J Roentgenol. 2014; 203(6). https://doi.org/10.2214/AJR.14.12646

15.

Cancer Research UK. Breast cancer statistics. Accessed January 16, 2023. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer.

16.

American Cancer Society. Survival rates for breast cancer. Revised March 1, 2022. Accessed January 13, 2023. https://www.cancer.org/cancer/breast-cancer/understanding-a-breast-cancer-diagnosis/breast-cancer-survival-rates.html.

17.

Grimm LJ, Avery CS, Hendrick E, and Baker JA. Benefits and risks of mammography screening in women ages 40 to 49 years. J Prim Care Commun Health. 2022;13. https://doi.org/10.1177/21501327211058322

18.

• Ahn S, Wooster M, Valente C, Moshier E, Meng R, Pisapati K, Couri R, Margolies L, Schmidt H, Port E. Impact of screening mammography on treatment in women diagnosed with breast cancer. Ann Surg Oncol. 2018; 25(10). https://doi.org/10.1245/s10434-018-6646-8. (Findings from this study evaluate the impact of screening mammography on treatment and subsequent clinical outcomes.)

19.

Overview of the treatment of newly diagnosed invasive, non-metastatic breast cancer – UpToDate. (n.d.). Retrieved December 7, 2022, from https://www.uptodate.com/contents/overview-of-the-treatment-of-newly-diagnosed-invasive-non-metastatic-breast-cancer?search=Overview%20of%20the%20treatment%20of%20newly%20diagnosed,%20invasive,%20non-metastatic%20breast%20cancer&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

20.

• Lee CS, Monticciolo DL, Moy L. Screening guidelines update for average-risk and high-risk women. Am J Roentgenol. 2020;214(2). https://doi.org/10.2214/AJR.19.22205. (Findings from this study compares and contrasts the average and high-risk breast cancer screening guidelines established by the American College of Radiology, American Society of Breast Surgeons, Society of Breast Imaging, National Comprehensive Cancer Network, National Consortium of Breast Centers, American Cancer Society, U.S. Preventive Services Task Force, American College of Physicians, and the American Academy of Family Physicians.)

21.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA. Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol. 2017; 14(9). https://doi.org/10.1016/j.jacr.2017.06.001

22.

Croes KD, Jones NR, DuBenske LL, et al. Core elements of shared decision-making for women considering breast cancer screening: results of a modified Delphi survey. J GEN INTERN MED. 2020;35:1668–77. https://doi.org/10.1007/s11606-019-05298-8.CrossRefPubMedPubMedCentral

23.

Mainiero MB, Lourenco A, Mahoney MC, Newell MS, Bailey L, Barke LD, D’Orsi C, Harvey JA, Hayes MK, Huynh PT, Jokich PM, Lee SJ, Lehman CD, Mankoff DA, Nepute JA, Patel SB, Reynolds HE, Sutherland ML, Haffty BG. ACR appropriateness criteria breast cancer screening. J Am Coll Radiol. 2016;13(11):R45–9. https://doi.org/10.1016/j.jacr.2016.09.021.CrossRefPubMed

24.

Siu AL. Screening for breast cancer: U.S. Preventive services task force recommendation statement. In Ann Int Med. 2016; 164(4). https://doi.org/10.7326/M15-2886

Title: The Benefits of Screening Mammography
Authors: Charles De Jesus
Tanya W. Moseley
Valentina Diaz
Varnita Vishwanath
Shanen Jean
Ahmed Elhatw
Hanna R. Ferreira Dalla Pria
Hannah L. Chung
Mary S. Guirguis
Miral M. Patel
Publication date: 04-04-2023
Publisher: Springer US
Keywords: Breast Cancer
Mammography
Breast Cancer
Mammography
Published in: Current Breast Cancer Reports / Issue 2/2023
Print ISSN: 1943-4588
Electronic ISSN: 1943-4596
DOI: https://doi.org/10.1007/s12609-023-00479-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 2/2023

Current Updates in Management of HER2-Positive and HER2-Low Breast Cancer

Pictorial Review of Male Breast Disease

Breast-to-Brain Metastasis: from Microenvironment to Plasticity

Advanced Breast Imaging Modalities — DBT, CEM, MBI, PEM, MRI, AI

Supplemental Screening for Breast Cancer

Breast Imaging Considerations in Symptomatic Young, Pregnant, and Lactating Women

Keynote webinar | Spotlight on antibody–drug conjugates in cancer